Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
7-{2,6-dichloro-4-[3-(2-chloro-benzoyl)-ureido]-phenoxy}-heptanoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of n-benzoyl-n'-phenylureas. It is identified by its IUPAC name as "7-[2,6-dichloro-4-{[(2-chlorophenyl)formamido]carbonyl}amino)phenoxy]heptanoic acid" and has a molecular formula of C21H21Cl3N2O5 with a molecular weight of approximately 487.8 g/mol[1][3][6]. The compound appears in chemical databases such as DrugBank (DB04642), PubChem (CID:5326884), and RCSB PDB (ligand code BN2)[1][6][2]. Its mechanism of action and pharmacological activity are not described in publicly available sources; it is listed as an experimental molecule with no approved therapeutic use or known clinical development status[1].
- Other names
- 7-[2,6-dichloro-4-({[(2-chlorophenyl)formamido]carbonyl}amino)phenoxy]heptanoic acid7-(2,6-dichloro-4-(3-(2-chloro-benzoyl)-ureido)-phenoxy)-heptanoic acid7-(2,6-dichloro-4-((((2-chlorophenyl)formamido)carbonyl)amino)phenoxy)heptanoic acid7-[2,6-DICHLORO-4-{[(2-chlorobenzoylamino)carbonyl]amino}PHENOXY]HEPTANOIC ACID
02
Targets
PYG (Glycogen phosphorylase)
Beyond the preview
Go deeper on 7-{2,6-dichloro-4-[3-(2-chloro-benzoyl)-ureido]-phenoxy}-heptanoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 7-{2,6-dichloro-4-[3-(2-chloro-benzoyl)-ureido]-phenoxy}-heptanoic acid.